Skip to main content

Call for papers - Artificial intelligence and tuberculosis screening

Guest Editors

Jacob Creswell, MPH, PhD, Stop TB Partnership, Switzerland
Luan Nguyen Quang Vo, MPH, Friends for International TB Relief (FIT), Vietnam

Submission Status: Open   |   Submission Deadline: 29 January 2026

BMC Global and Public Health is calling for submissions to our Collection on advancing diagnostic innovation for global health challenges. This Collection highlights the potential of artificial intelligence (AI) to transform tuberculosis (TB) diagnosis and screening, particularly through tools like chest X-ray (CXR) analysis. We seek research on integrating AI into public health systems, improving active case finding, and addressing barriers to equitable access in TB care worldwide.

New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health and Well-being and SDG 10: Reduced Inequalities.

Meet the Guest Editors

Back to top

Jacob Creswell, MPH, PhD, Stop TB Partnership, Switzerland

Jacob is a public health researcher with 25 years of experience in TB and HIV program implementation, design, and evaluation. He has considerable experience working on TB and MDR-TB program delivery in Latin America, Africa, and Asia. His research focuses on improving TB case detection through innovative diagnostics and novel interventions. He currently leads TB REACH and the Digital Health Technology Hub at Stop TB Partnership, where he manages a large portfolio of grants seeking to improve TB care and treatment for the most vulnerable populations who are often missed by routine health services. His research has played a critical role in evidence generation for global policy development in the areas of TB screening, private sector engagement, new diagnostic tools, and artificial intelligence applications in TB.

Luan Nguyen Quang Vo, MPH, Friends for International TB Relief (FIT), Vietnam

Luan is the president of Friends for International TB Relief and a technical advisor for IRDVN in Vietnam. He supports Vietnam’s NTP in evidence generation for active case finding, private sector engagement, social protection, diagnostics, and prevention. He co-led the 2015-2020 Program Review and has been on Vietnam’s Global Fund Sub-CCM for TB since 2021. He is Treasurer of The Union, and a member of the Stop TB Partnership Board's Innovation Constituency and WHO’s Civil Society Task Force on TB. Luan is a PhD candidate with Karolinska Institutet and holds an MPH from LSHTM and a BSE in bioengineering and mathematics from the University of Pennsylvania.

About the Collection

BMC Global and Public Health is calling for submissions to our Collection on innovative approaches to addressing pressing health challenges in resource-limited settings. This initiative aims to bring together cutting-edge research and interdisciplinary insights to advance global health equity and improve outcomes for vulnerable populations. This Collection specifically seeks to explore the transformative potential of artificial intelligence (AI) in reshaping strategies for tuberculosis (TB) diagnosis in community- and facility-based active case finding. It invites studies leveraging AI tools, particularly those applied to chest X-ray (CXR) analysis, to enhance the accuracy, speed, and accessibility of TB screening and confirmatory rapid molecular diagnostics. We welcome research on the integration of AI technologies in public health systems, assessments of their impact on TB care pathways, and investigations of ethical, societal, and operational challenges.

The Collection’s goals include:

  • Advancing evidence on the use of AI for improving the efficiency and reliability of TB screening methods.
  • Exploring the role of AI-enhanced CXR analysis in active case finding efforts across diverse populations and varieties of settings.
  • Evaluating the cost-effectiveness and scalability of AI solutions for TB diagnosis in low- and middle-income countries.
  • Addressing ethical and equity considerations in the deployment of AI for global health initiatives.
  • Assessing psychological, commercial, and regulatory enablers and barriers in market access and supply chain, data protection and security, acceptance/hesitancy and uptake, pricing, and affordability of AI for TB.
  • Proposing frameworks for integrating AI-driven screening tools into existing healthcare infrastructures.

By fostering a multidisciplinary dialogue, this Collection aims to define pathways for responsibly harnessing AI technologies in TB care and prevention efforts.

We encourage work from local, regional, national, and global partnerships and collaboration among multidisciplinary scientists using multiple methodologies. We ask that authors use non-stigmatizing/patient-centered language as outlined in relevant language guidelines for their respective fields.

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being and SDG 10: Reduced Inequalities.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Image credit: © adam121 / stock.adobe.com

There are currently no articles in this collection.

Submission Guidelines

This Collection welcomes submissions of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, SNAPP. During the submission process you will be asked whether you are submitting to a Collection, please select "Artificial intelligence and tuberculosis screening" from the dropdown menu.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.